BIOGEN INC. - 26 Sep 2023 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Role
10%+ Owner
Signature
BIOGEN INC. By: /s/ Michael Dambach, Vice President and Treasurer
Issuer symbol
SGMO
Transactions as of
26 Sep 2023
Net transactions value
-$3,000,000
Form type
4
Filing time
28 Sep 2023, 17:30:09 UTC
Previous filing
07 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMO Common Stock Sale $3,000,000 -6,000,000 -25% $0.5000 17,652,466 26 Sep 2023 By Biogen MA Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

BIOGEN INC. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.